| Not Yet Recruiting | Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Trans Hematopoietic and Lymphatic System Neoplasm | Phase 2 | 2026-09-01 |
| Not Yet Recruiting | A Behavioral Application for Improving Smoking Cessation Among Smokers Cigarette Smoking-Related Carcinoma | N/A | 2026-08-01 |
| Not Yet Recruiting | Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukem Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | 2026-07-01 |
| Not Yet Recruiting | A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Indi Lung Carcinoma | N/A | 2026-07-01 |
| Not Yet Recruiting | Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2026-06-01 |
| Not Yet Recruiting | Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Com Human Papillomavirus-Related Carcinoma | N/A | 2026-06-01 |
| Not Yet Recruiting | ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor St Multiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Wa Lung Carcinoma | N/A | 2026-06-01 |
| Not Yet Recruiting | A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Cigarette Smoking-Related Carcinoma | N/A | 2026-06-01 |
| Not Yet Recruiting | Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukem Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Neoplasm | N/A | 2026-06-01 |
| Not Yet Recruiting | iCanQuit Smoking Cessation Among Hispanic Adults Cigarette Smoking-Related Carcinoma | Phase 3 | 2026-05-01 |
| Not Yet Recruiting | Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease Chronic Graft Versus Host Disease, Acute Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm | N/A | 2026-05-01 |
| Recruiting | Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Pati Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm | N/A | 2026-05-01 |
| Not Yet Recruiting | A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial Malignant Solid Neoplasm | N/A | 2026-05-01 |
| Not Yet Recruiting | Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treat Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2026-05-01 |
| Recruiting | Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicia Ovarian Carcinoma, Psychiatric Disorder | N/A | 2026-05-01 |
| Not Yet Recruiting | A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users Nicotine Dependence, Tobacco-Related Carcinoma | N/A | 2026-04-30 |
| Not Yet Recruiting | Effect of Meal Timing During Adjuvant Treatment for Cancer Cancer | N/A | 2026-04-01 |
| Recruiting | Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial Rectal Cancer Stage II, Rectal Cancer Stage III, Breast Cancer Stage I | N/A | 2026-03-31 |
| Recruiting | Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relap Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2026-03-24 |
| Not Yet Recruiting | Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positiv HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer | N/A | 2026-03-01 |
| Not Yet Recruiting | Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positiv HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer | N/A | 2026-03-01 |
| Recruiting | Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and My Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | 2026-02-04 |
| Recruiting | Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-s Lung Non-Small Cell Carcinoma | N/A | 2026-01-28 |
| Recruiting | Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance IgA Monoclonal Gammopathy of Undetermined Significance | Phase 2 | 2026-01-22 |
| Recruiting | Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/P Advanced Osteosarcoma, Recurrent Osteosarcoma, Refractory Osteosarcoma | Phase 1 | 2026-01-16 |
| Recruiting | ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lym Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma | Phase 1 / Phase 2 | 2025-12-27 |
| Recruiting | Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals Hematopoietic and Lymphatic System Neoplasm, Autoimmune Disease, Respiratory Syncytial Virus Infection | Phase 2 | 2025-12-23 |
| Enrolling By Invitation | A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immuno Colorectal Carcinoma | N/A | 2025-12-16 |
| Withdrawn | EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico Cigarette Smoking-Related Carcinoma | N/A | 2025-12-01 |
| Recruiting | Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8 | N/A | 2025-11-17 |
| Recruiting | Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in He Hematopoietic and Lymphatic System Neoplasm | N/A | 2025-10-21 |
| Recruiting | Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | 2025-09-26 |
| Recruiting | Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Old Aplastic Anemia | Phase 2 | 2025-09-25 |
| Recruiting | Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Mixed Phenotype Acute Leukemia | Phase 1 / Phase 2 | 2025-09-23 |
| Withdrawn | Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neopla Pancreatic Neoplasm | N/A | 2025-09-01 |
| Recruiting | Axatilimab for Sclerotic Chronic Graft-versus-Host Disease Chronic Graft Versus Host Disease | Phase 2 | 2025-08-06 |
| Recruiting | Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Sur Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Colorectal Carcinoma | N/A | 2025-07-08 |
| Recruiting | A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma Metastatic Sarcoma, Sarcoma | N/A | 2025-07-08 |
| Recruiting | A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQ Cigarette Smoking-Related Carcinoma | N/A | 2025-07-03 |
| Active Not Recruiting | Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru HIV/AIDS, Mobile Health, Feasibility Studies | N/A | 2025-06-12 |
| Recruiting | Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lym Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia | Phase 2 | 2025-06-02 |
| Active Not Recruiting | Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Surviv Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2025-05-16 |
| Withdrawn | Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Pa Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 | Phase 1 | 2025-04-15 |
| Recruiting | Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2025-04-08 |
| Withdrawn | Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2025-04-01 |
| Recruiting | Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia Financial Hardship, Alzheimer's Disease (AD), Alzheimer's Disease and Related Dementia (ADRD) | — | 2025-03-31 |
| Enrolling By Invitation | Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, A Lung Carcinoma | N/A | 2025-03-01 |
| Recruiting | FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Recurrent Childhood Acute Myeloid Leukemia, Refractory Childhood Acute Myeloid Leukemia | Phase 1 | 2025-02-24 |
| Suspended | Helping Ovarian Cancer Patients Cope With Their Illness (HOPE) Recurrent Ovarian Carcinoma | N/A | 2025-02-24 |
| Recruiting | Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning Malignant Solid Neoplasm | N/A | 2025-02-18 |
| Recruiting | Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disea Intestinal Graft Versus Host Disease | Phase 1 | 2025-01-24 |
| Recruiting | Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistan Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 1 / Phase 2 | 2024-11-26 |
| Recruiting | Improving Engagement in HIV and Cancer Care in Zimbabwe Cancer, HIV | N/A | 2024-11-18 |
| Completed | Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm | N/A | 2024-11-08 |
| Completed | A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hemat Multiple Myeloma | N/A | 2024-10-14 |
| Recruiting | Cooking for Your Health in Southern New Mexico: an 8-week, Bilingual (English and Spanish) Nutritional Interve Dietary Carcinogenesis, Nutrition, Healthy | N/A | 2024-10-12 |
| Completed | Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2024-09-23 |
| Suspended | DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hem Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1 | 2024-09-23 |
| Recruiting | Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | 2024-09-18 |
| Recruiting | Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hig Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2024-07-23 |
| Recruiting | High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial Melanoma (Skin), Skin Cancer, Advanced Melanoma | N/A | 2024-07-01 |
| Recruiting | IVIG for Infection Prevention After CAR-T-Cell Therapy Hematologic Malignancies | Phase 2 | 2024-06-10 |
| Completed | Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement Cancer | N/A | 2024-06-06 |
| Completed | Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced C Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | N/A | 2024-05-21 |
| Completed | An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutri Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2024-03-07 |
| Terminated | Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacie Human Papillomavirus-Related Carcinoma | N/A | 2024-02-28 |
| Withdrawn | Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Tre Plasma Cell Myeloma | Phase 1 | 2024-01-27 |
| Completed | H-PACE Program for the Improvement of Lifestyle Behaviors Among Children Pediatric Obesity | N/A | 2024-01-22 |
| Completed | A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults Nicotine Dependence, Nicotine Addiction, Nicotine Use Disorder | N/A | 2024-01-04 |
| Active Not Recruiting | Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagno Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome | Phase 1 | 2023-12-18 |
| Recruiting | Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Recepto Metastatic Malignant Solid Neoplasm | Phase 1 | 2023-12-15 |
| Active Not Recruiting | Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Al Acute Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm | Phase 2 | 2023-12-12 |
| Recruiting | Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease Chronic Graft Versus Host Disease | Phase 2 | 2023-12-06 |
| Completed | Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults Cigarette Smoking-Related Carcinoma | N/A | 2023-08-20 |
| Active Not Recruiting | Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | 2023-08-11 |
| Completed | Pharmacy-based PrEP Delivery in Kenya Hiv | N/A | 2023-06-20 |
| Recruiting | Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia | Phase 2 | 2023-05-31 |
| Completed | A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test Colorectal Carcinoma | N/A | 2023-05-15 |
| Withdrawn | Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Rec Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 1 | 2023-04-01 |
| Active Not Recruiting | NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymph Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma | Phase 1 | 2022-12-08 |
| Completed | Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines Tuberculosis | Phase 1 | 2022-12-06 |
| Active Not Recruiting | Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic Malignant Female Reproductive System Neoplasm | N/A | 2022-11-14 |
| Completed | Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Can Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8 | N/A | 2022-10-23 |
| Terminated | A Multilevel Approach for Improvement in Screening of Colorectal Cancer in Rural Communities, The Screen to Sa Colorectal Carcinoma | N/A | 2022-10-08 |
| Terminated | Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia | Phase 2 | 2022-10-06 |
| Active Not Recruiting | An Innovative Conversational Agent (Quitbot) for Smoking Cessation Cigarette Smoking-Related Carcinoma | Phase 3 | 2022-07-24 |
| Recruiting | Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Hematopoietic and Lymphatic System Neoplasm | N/A | 2022-06-22 |
| Recruiting | Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positiv Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Cutaneous Melanoma | Phase 1 | 2022-06-09 |
| Terminated | A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle Lung Carcinoma | N/A | 2022-06-06 |
| Active Not Recruiting | Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | N/A | 2022-06-06 |
| Terminated | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV AIDS-Related Kaposi Sarcoma, HIV Infection, Kaposi Sarcoma | Phase 1 | 2022-05-23 |
| Active Not Recruiting | Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Ac Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | 2022-05-10 |
| Completed | mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation Cigarette Smoking-Related Carcinoma | Phase 1 | 2022-05-09 |
| Completed | Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marro Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia | Phase 2 | 2022-04-19 |
| Withdrawn | Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxio Social Anxiety Disorder, Tobacco Use Disorder | Phase 1 | 2022-04-15 |
| Recruiting | The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoi Bronchiolitis Obliterans Syndrome, Hematopoietic and Lymphoid Cell Neoplasm | — | 2022-03-30 |
| Active Not Recruiting | Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO T HIV Infection | Phase 4 | 2022-03-10 |
| Completed | Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya HIV Prevention | N/A | 2022-02-24 |
| Terminated | Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | 2022-01-25 |
| Completed | Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin B-Cell Non-Hodgkin Lymphoma | Phase 2 | 2021-12-27 |
| Terminated | Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 1 | 2021-12-14 |
| Completed | Red and Processed Meat Effects on the Metabolome and Microbiome Controlled Feeding Trial, Healthy Eating Index, Red Meat | N/A | 2021-11-16 |
| Completed | Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With P Localized Prostate Carcinoma, Prostate Adenocarcinoma | N/A | 2021-11-04 |
| Terminated | eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | N/A | 2021-09-16 |
| Completed | Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Ai Lung Carcinoma | N/A | 2021-09-15 |
| Terminated | CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measur Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2, Myeloid Neoplasm | Phase 2 | 2021-08-09 |
| Terminated | Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm | Phase 1 / Phase 2 | 2021-07-19 |
| Active Not Recruiting | Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | Phase 3 | 2021-07-19 |
| Terminated | Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis Acute Respiratory Failure | Phase 3 | 2021-06-29 |
| Withdrawn | Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis Af Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | 2021-06-01 |
| Completed | An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis Endometriosis | N/A | 2021-05-24 |
| Active Not Recruiting | Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Tra Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm | Phase 2 | 2021-05-14 |
| Recruiting | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder | Phase 2 | 2021-05-05 |
| Active Not Recruiting | Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study Obesity-Related Malignant Neoplasm | Phase 3 | 2021-03-05 |
| Recruiting | Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | 2021-02-09 |
| Completed | Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV Lung Carcinoma | — | 2021-02-05 |
| Completed | Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans Cigarette Smoking-Related Carcinoma | Phase 1 | 2021-02-03 |
| Completed | Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study Human Papillomavirus Infection | N/A | 2021-02-01 |
| Recruiting | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hemat Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2021-01-25 |
| Completed | Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Blad Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 | Phase 2 | 2021-01-22 |
| Completed | Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnose Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | N/A | 2021-01-22 |
| Completed | Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer Healthy Subject | N/A | 2021-01-05 |
| Completed | PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | N/A | 2021-01-01 |
| Active Not Recruiting | Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | 2020-12-18 |
| Active Not Recruiting | Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm | Phase 2 | 2020-12-11 |
| Recruiting | CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatmen Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome | Phase 1 | 2020-12-03 |
| Completed | Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma | N/A | 2020-11-18 |
| Completed | Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Hematopoietic and Lymphoid Cell Neoplasm | Phase 3 | 2020-10-29 |
| Completed | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach Breast Carcinoma, Colon Carcinoma, Malignant Solid Neoplasm | N/A | 2020-08-03 |
| Completed | Vaccine Responsiveness After CAR-T Cell Therapy B-Cell Neoplasm | Phase 1 | 2020-08-03 |
| Recruiting | Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study Chronic Graft Versus Host Disease | — | 2020-06-29 |
| Recruiting | Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Non-Malignant Neoplasm | Phase 1 / Phase 2 | 2020-06-16 |
| Completed | Flexiquit+: Web Program to Promote Smoking Cessation in Sexual and Gender Minority Young Adult Smokers Tobacco Use Disorder | Phase 1 | 2020-05-18 |
| Active Not Recruiting | CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Acute Myeloid Leukemia, Myeloid Neoplasm | Phase 2 | 2020-03-11 |
| Completed | Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Act Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 2 | 2020-02-21 |
| Completed | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMP Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma | N/A | 2020-02-19 |
| Withdrawn | Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem C Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Phase 1 | 2020-01-02 |
| Terminated | Glasdegib for Chronic Graft-Versus-Host Disease Chronic Graft Versus Host Disease, Fasciitis | Phase 1 / Phase 2 | 2019-12-03 |
| Recruiting | Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukem Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2019-11-19 |
| Completed | Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy P Healthy Subject | N/A | 2019-10-28 |
| Terminated | Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, Diffuse Large B-Cell Lymphoma | Phase 1 | 2019-10-24 |
| Terminated | Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma | Phase 1 | 2019-09-30 |
| Completed | Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study Hematopoietic and Lymphoid Cell Neoplasm | — | 2019-09-13 |
| Terminated | Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Solid Neoplasm | Phase 1 | 2019-09-03 |
| Recruiting | Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Bloo Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage | Phase 2 | 2019-08-29 |
| Terminated | Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Olde Hematopoietic and Lymphoid Cell Neoplasm, Non-Neoplastic Hematologic and Lymphocytic Disorder | Phase 2 / Phase 3 | 2019-08-15 |
| Completed | Yeego! Healthy Eating & Gardening School-Based Randomized Controlled Trial Dietary Habits, Health Behavior, Eating Behavior | N/A | 2019-08-05 |
| Recruiting | 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Ris Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission | Phase 1 / Phase 2 | 2019-07-10 |
| Terminated | Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Canc Other Skin | Phase 1 / Phase 2 | 2019-07-03 |
| Terminated | Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors Colon Cancer, Rectal Cancer, Cancer Survivor | Phase 2 | 2019-05-07 |
| Terminated | Acute Exercise Intervention in Breast Cancer Survivors Breast Carcinoma | N/A | 2019-03-25 |
| Terminated | Reducing Insulin, Growth Hormones, and Tumors Diet Modification, Lung Cancer | N/A | 2018-12-21 |
| Enrolling By Invitation | Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study Prostate Carcinoma | — | 2018-11-30 |
| Completed | Resistance Training Program and Cardiovascular Exercise in Increasing Muscle Mass in Adolescent and Young Adul Malignant Neoplasm | N/A | 2018-11-21 |
| Terminated | A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort Diabetes, Type2 Diabetes, Diabetes Mellitus | — | 2018-10-15 |
| Completed | Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot) Smoking Cessation | N/A | 2018-09-17 |
| Completed | Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2018-09-14 |
| Withdrawn | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal | Phase 4 | 2018-09-01 |
| Completed | SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart Acute Leukemia in Remission, Hematopoietic Cell Transplantation Recipient, Lymphoma | N/A | 2018-08-31 |
| Completed | Pilot Trial of a Telephone Weight Loss, Nutrition, Exercise Study Weight Loss, Weight, Body | N/A | 2018-08-29 |
| Withdrawn | Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative A Acute Myeloid Leukemia, Minimal Residual Disease Negativity | Phase 2 | 2018-07-10 |
| Withdrawn | Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 | Phase 2 | 2018-06-19 |
| Completed | Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Di Chronic Graft Versus Host Disease | Phase 2 | 2018-06-06 |
| Completed | Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer Breast Cancer Female, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 1 | 2018-06-06 |
| Terminated | BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 | 2018-05-23 |
| Completed | Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregi Hematopoietic Cell Transplantation Recipient | N/A | 2018-05-18 |
| Completed | Glucosamine and Chondroitin in Gut in Preventing People From Inflammation Healthy Subject | Phase 1 | 2018-05-11 |
| Completed | Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8 | N/A | 2018-04-18 |
| Completed | Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study) Cancer, Smoking | N/A | 2018-04-02 |
| Completed | Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma | Phase 1 / Phase 2 | 2018-03-28 |
| Recruiting | HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia | Phase 1 | 2018-02-23 |
| Completed | MMF for HIV Reservoir Reduction Human Immunodeficiency Virus I Infection | Phase 2 | 2018-02-12 |
| Active Not Recruiting | A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Exp Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2017-12-05 |
| Completed | Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple My Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 | 2017-11-29 |
| Completed | Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers Caregiver, Solid Neoplasm | N/A | 2017-11-15 |
| Terminated | Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed A Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present | Phase 1 / Phase 2 | 2017-11-06 |
| Terminated | huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Ac Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | 2017-11-03 |
| Recruiting | 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, A Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2017-10-24 |
| Terminated | Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Metastatic Leiomyosarcoma, Metastatic Liposarcoma, Unresectable Leiomyosarcoma | Phase 1 / Phase 2 | 2017-09-28 |
| Terminated | Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelate Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma | Phase 2 | 2017-09-11 |
| Completed | Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use HIV Infection | N/A | 2017-08-28 |
| Completed | Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients Healthy Subject, Overweight | Phase 1 | 2017-08-01 |
| Terminated | HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion | Phase 4 | 2017-08-01 |
| Terminated | Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2017-06-09 |
| Completed | Trial of An Innovative Smartphone Intervention for Smoking Cessation Smoking | N/A | 2017-05-27 |
| Completed | Mindset Intervention for Nicotine Dependence Psychology, Social, Smoking Cessation, Smoking (Tobacco) Addiction | N/A | 2017-05-26 |
| Terminated | Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer Advanced Malignant Neoplasm | N/A | 2017-04-05 |
| Completed | Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder Smoking, Bipolar Disorder | N/A | 2017-04-03 |
| Terminated | Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia, Myelodysplastic Syndrome | Phase 2 | 2017-03-02 |
| Completed | Communicating Health Information and Improving Coordination With Primary Care Hypertension, Dyslipidemias, Diabetes | N/A | 2017-03-01 |
| Terminated | Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, Diffuse Large B-Cell Lymphoma | Phase 1 | 2017-02-01 |
| Completed | Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Sarcoma | Phase 1 / Phase 2 | 2016-12-05 |
| Completed | Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2016-11-17 |
| Terminated | JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Phase 1 | 2016-11-15 |
| Completed | Engaging School and Family in Navajo Gardening for Health Dietary Habits, Eating Behavior, Health Behavior | N/A | 2016-10-21 |
| Withdrawn | HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection Human Immunodeficiency Virus 1 Positive, Stage I Adult Hodgkin Lymphoma, Stage I Adult Non-Hodgkin Lymphoma | Phase 1 | 2016-08-15 |
| Withdrawn | Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma AIDS-Related Hodgkin Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection | Phase 1 | 2016-06-22 |
| Terminated | Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC V7, Stage IIA Prostate Cancer AJCC v7 | N/A | 2016-05-19 |
| Completed | Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors Cancer Survivor, Stage 0 Breast Cancer, Stage IA Breast Cancer | N/A | 2016-05-01 |
| Completed | Together We STRIDE (Strategizing Together Relevant Interventions for Diet and Exercise) Obesity, Childhood | N/A | 2016-04-01 |
| Completed | The Vaginal Health Trial Atrophy of Vagina, Menopause, Dyspareunia (Female) | Phase 3 | 2016-04-01 |
| Terminated | Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma | Phase 1 | 2016-03-16 |
| Withdrawn | Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small L Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Non-Hodgkin Lymphoma | Phase 2 | 2016-03-01 |
| Completed | Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors Breast Carcinoma, Cancer Survivor | N/A | 2016-02-03 |
| Withdrawn | Tocilizumab for Chronic Graft-versus-Host Disease Treatment Graft Versus Host Disease | Phase 2 | 2016-02-01 |
| Completed | Hypnotherapy in Treating Chronic Pain in Cancer Survivors Anxiety, Cancer Survivor, Chronic Pain | N/A | 2016-01-08 |
| Completed | The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study) Insulin Resistance, Metabolic Syndrome, Obesity | N/A | 2016-01-01 |
| Completed | Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Pa Plasma Cell Myeloma, Transplant-Related Carcinoma | Phase 2 | 2015-12-30 |
| Completed | Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease Chronic Graft Versus Host Disease | Phase 2 | 2015-12-08 |
| Completed | Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease Chronic Graft Versus Host Disease | Phase 2 | 2015-11-12 |
| Terminated | Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immu Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 | Phase 1 / Phase 2 | 2015-11-06 |
| Completed | Telephone-Delivered Interventions for Smoking Cessation Smoking | N/A | 2015-11-02 |
| Completed | Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda HIV/AIDS and Infections | Phase 4 | 2015-11-01 |
| Completed | HSV529 Vaccine in HSV-2 Seropositive Adults Herpes Simplex Virus 2 | Phase 1 | 2015-11-01 |
| Completed | Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors Breast Carcinoma, Cancer Survivor, Depression | N/A | 2015-08-03 |
| Completed | Diet and Metabolic Inflammation Insulin Resistance, Diabetes, Cancer | N/A | 2015-08-01 |
| Terminated | Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma | Phase 1 / Phase 2 | 2015-05-22 |
| Completed | Women's Health Initiative Strong and Healthy Study Myocardial Infarction, Stroke, Cardiovascular Mortality | N/A | 2015-04-02 |
| Completed | theFRESHstudy: FRequency of Eating and Its Influence on Satiety and Health Healthy | N/A | 2015-04-01 |
| Completed | Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Rela Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage | Phase 2 | 2015-02-03 |
| Withdrawn | Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgki Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | N/A | 2015-02-01 |
| Terminated | Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid L Acute Myeloid Leukemia, Myelodysplastic Syndrome | N/A | 2015-01-09 |
| Completed | NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Sarcoma | Phase 1 | 2015-01-01 |
| Completed | TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma | Phase 1 | 2014-11-17 |
| Terminated | Blood Samples to Identify Biomarkers of Busulfan Leukemia, Lymphoma, Multiple Myeloma | — | 2014-11-01 |
| Completed | SmartQuit Program for Smoking Cessation Cigarette Smoking-Related Carcinoma, Tobacco-Related Carcinoma | N/A | 2014-10-22 |
| Completed | JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | 2014-10-20 |
| Completed | Cancer Communication Within Hispanic Social Networks Colorectal Carcinoma | N/A | 2014-09-09 |
| Completed | TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors Endometrial Cancer | N/A | 2014-07-01 |
| Withdrawn | NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid Adult Synovial Sarcoma, Myxoid/Round Cell Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 | 2014-07-01 |
| Completed | Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder HIV, Alcohol Use Disorder | Phase 4 | 2014-05-01 |
| Completed | Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage | Phase 2 | 2014-04-10 |
| Completed | Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit) Smoking | N/A | 2014-03-24 |
| Completed | Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed o Acute Biphenotypic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome | Phase 1 / Phase 2 | 2014-01-23 |
| Unknown | Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leuke Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease | Phase 2 | 2013-11-01 |
| Completed | MsFLASH-04: Pilot Trial: Telephone Behavioral Therapy for Menopause-related Sleep Disturbance Hot Flashes, Menopause, Vasomotor Disturbance | N/A | 2013-11-01 |
| Completed | Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) Graft-Versus-Host Disease (GVHD) Acute on Chronic | Phase 1 / Phase 2 | 2013-10-11 |
| Completed | Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2013-10-09 |
| Terminated | Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma | EARLY_Phase 1 | 2013-09-25 |
| Completed | Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma Mucosal Melanoma, Recurrent Melanoma, Recurrent Uveal Melanoma | Phase 2 | 2013-09-13 |
| Completed | CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | 2013-09-10 |
| Completed | Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 | Phase 2 | 2013-08-20 |
| Completed | Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome | Phase 2 | 2013-08-19 |
| Completed | Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | — | 2013-07-19 |
| Completed | HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women HIV | Phase 4 | 2013-07-01 |
| Withdrawn | Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Hematopoietic/Lymphoid Cancer | Phase 1 / Phase 2 | 2013-06-01 |
| Active Not Recruiting | Chronic GVHD Response Measures Validation Graft vs Host Disease | — | 2013-06-01 |
| Completed | Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non- CD19-Positive Neoplastic Cells Present, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2013-05-22 |
| Completed | INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who U Cancer Survivor, Depression, Hematopoietic and Lymphoid Cell Neoplasm | Phase 3 | 2013-05-14 |
| Completed | Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acut Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | N/A | 2013-05-07 |
| Completed | Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodyspla Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a) | N/A | 2013-05-01 |
| Completed | Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant Hematopoietic/Lymphoid Cancer | N/A | 2013-04-01 |
| Completed | Comparing Different Methods for Collection of Comorbidity Data Per the HCT-CI Hematopoietic Malignancy | — | 2013-03-22 |
| Completed | Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit) Smoking | N/A | 2013-03-01 |
| Terminated | Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma Recurrent Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma | Phase 1 / Phase 2 | 2013-02-01 |
| Completed | Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapse Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2012-12-20 |
| Terminated | Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplasti Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2012-12-06 |
| Completed | Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood an Hyperglycemia, Malignant Neoplasm | N/A | 2012-12-01 |
| Completed | FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health Healthy | N/A | 2012-10-01 |
| Completed | Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life Hematologic Malignancies, Other Diagnoses, Comorbidities, and Complications | — | 2012-10-01 |
| Completed | Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia | Phase 2 | 2012-09-25 |
| Completed | Glucosamine and Chondroitin Effects Inflammation | N/A | 2012-09-01 |
| Terminated | Crohn's Allogeneic Transplant Study Crohn Disease | Phase 2 | 2012-07-17 |
| Terminated | Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) | Phase 2 | 2012-07-01 |
| Completed | Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease Graft Versus Host Disease, Ophthalmologic Complications | Phase 2 | 2012-06-01 |
| Completed | Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myel Malignant Neoplasm | Phase 2 | 2012-05-01 |
| Terminated | Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic L Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 2 | 2012-05-01 |
| Completed | Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloi Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | 2012-05-01 |
| Completed | CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2012-04-01 |
| Completed | Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy Smoking | N/A | 2012-03-01 |
| Completed | Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Me Recurrent Melanoma, Stage IV Melanoma | Phase 1 | 2012-03-01 |
| Terminated | Gene Therapy for Fanconi Anemia Fanconi Anemia | Phase 1 | 2012-02-22 |
| Completed | 90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Periphe Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 | 2012-01-09 |
| Completed | Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 | 2012-01-01 |
| Completed | Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Ca Adult Liposarcoma, Adult Synovial Sarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 | 2012-01-01 |
| Terminated | High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Rel Post-Transplant Lymphoproliferative Disorder, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma | Phase 2 | 2011-11-16 |
| Completed | Vitamin D and Adipose Tissue Inflammation Vitamin D Deficiency, Obesity, Type 2 Diabetes Mellitus | N/A | 2011-11-01 |
| Completed | MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms Hot Flashes, Menopause, Vasomotor Disturbance | N/A | 2011-11-01 |
| Terminated | Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Phase 2 | 2011-11-01 |
| Completed | Diet and Systemic Inflammation Low-grade Chronic Inflammation, Intestinal Permeability, Type 2 Diabetes Mellitus | N/A | 2011-10-01 |
| Completed | COMIDAS Comparing Original Mexican Diets and Standard US Diets Healthy | N/A | 2011-10-01 |
| Completed | Scleroderma Treatment With Autologous Transplant (STAT) Study Systemic Scleroderma | Phase 2 | 2011-09-15 |
| Completed | Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Trans Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7) | Phase 2 | 2011-09-01 |
| Completed | Cervical Cancer Screening Among Hispanic Women Cervical Cancer | N/A | 2011-09-01 |
| Completed | PATH Partnering to Achieve Tobacco-free Health Smoking Cessation | Phase 1 / Phase 2 | 2011-06-01 |
| Terminated | Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a) | Phase 1 / Phase 2 | 2011-04-01 |
| Completed | Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Fail Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure | Phase 2 | 2011-03-10 |
| Completed | Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation Graft vs Host Disease, Cutaneous Sclerosis, Bronchiolitis Obliterans | — | 2011-03-01 |
| Completed | Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Do Acute Myeloid Leukemia | Phase 2 | 2011-01-25 |
| Completed | Meals and Grazing Study Healthy | N/A | 2011-01-01 |
| Completed | Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patient Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma | Phase 2 | 2010-12-01 |
| Completed | Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previ Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a) | Phase 2 | 2010-12-01 |
| Completed | Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Non-Hodgkin Lymphoma | Phase 2 | 2010-11-09 |
| Completed | Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma | Phase 3 | 2010-11-01 |
| Completed | MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercis Hot Flashes, Menopause, Vasomotor Symptoms | N/A | 2010-11-01 |
| Completed | Vitamin D, Diet and Activity Study Breast Cancer, Obesity, Hypovitaminosis D | N/A | 2010-10-01 |
| Completed | Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients Wi Adult Diffuse Large B-Cell Lymphoma, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 2 | 2010-09-02 |
| Completed | Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 / Phase 2 | 2010-09-01 |
| Completed | Effects of Sulforaphane on Normal Prostate Tissue Prostate Cancer | Phase 1 / Phase 2 | 2010-07-01 |
| Completed | Malaria Clinical Trials Center General Screening Malaria | — | 2010-06-01 |
| Completed | WebQuit Online Smoking Cessation Study Smoking | Phase 1 | 2010-06-01 |
| Terminated | Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Bloo Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | N/A | 2010-06-01 |
| Terminated | Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission | Phase 2 | 2010-05-19 |
| Completed | Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients Leukemia, Hodgkin Disease, Non-Hodgkin Lymphoma | — | 2010-05-01 |
| Completed | Screening Mammography and Latinas: A Multilevel Intervention Breast Cancer | N/A | 2010-05-01 |
| Completed | Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High- Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome | Phase 1 | 2010-04-21 |
| Terminated | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Mel Stage IV Melanoma | Phase 1 | 2010-04-01 |
| Completed | Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or A Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 2 | 2010-04-01 |
| Completed | Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p | Phase 2 | 2010-03-18 |
| Terminated | Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes | Phase 2 | 2009-12-17 |
| Completed | Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection | Phase 2 | 2009-12-17 |
| Completed | A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women Epithelial Ovarian Cancer | N/A | 2009-11-01 |
| Completed | Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Non-Neoplastic Hematologic and Lymphocytic Disorder | Phase 2 | 2009-07-31 |
| Completed | MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women Hot Flashes, Menopause, Vasomotor Symptoms | N/A | 2009-07-01 |
| Completed | Health SMART (Stress Management and Relaxation Training) Breast Cancer | Phase 2 | 2009-07-01 |
| Terminated | Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-I Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma | Phase 1 / Phase 2 | 2009-07-01 |
| No Longer Available | Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma Melanoma (Skin) | — | 2009-06-01 |
| Completed | Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Di Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 3 | 2009-06-01 |
| Completed | Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untrea Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | 2009-06-01 |
| Completed | TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients Influenza | Phase 1 / Phase 2 | 2009-03-01 |
| Terminated | O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients Wi Glioblastoma, Gliosarcoma | Phase 1 / Phase 2 | 2009-02-25 |
| Completed | Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer W Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Phase 2 | 2009-02-24 |
| Withdrawn | Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphoc Leukemia, Lymphoma | Phase 2 | 2009-02-01 |
| Completed | Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refracto B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia | Phase 2 | 2009-02-01 |
| Completed | Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Pa Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2009-02-01 |
| Completed | Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell T DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma | Phase 2 | 2009-02-01 |
| Terminated | Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma | Phase 1 | 2009-02-01 |
| Completed | Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma Recurrent Melanoma, Stage IV Melanoma | Phase 1 / Phase 2 | 2009-02-01 |
| Completed | Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myel Leukemia, Myelodysplastic Syndromes | N/A | 2008-12-01 |
| Completed | Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 / Phase 2 | 2008-11-01 |
| Completed | Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2008-10-13 |
| Completed | Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Refractory Plasma Cell Myeloma | Phase 2 | 2008-10-01 |
| Completed | Blood Samples to Evaluate Biomarkers of Donor Chimerism Leukemia, Hodgkins Disease, Non-hodgkins Lymphoma | — | 2008-09-01 |
| Completed | Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blastic Phase Chronic Myelogenous Leukemia | Phase 1 / Phase 2 | 2008-08-14 |
| Completed | Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2008-08-08 |
| Completed | Prevention of Ovarian Cancer in Women Participating in Mammography Epithelial Ovarian Cancer | N/A | 2008-07-01 |
| Completed | Partnership for a Hispanic Diabetes Prevention Program Diabetes, Pre-diabetes | N/A | 2008-07-01 |
| Completed | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma | Phase 2 | 2008-06-25 |
| Active Not Recruiting | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune | Phase 2 | 2008-06-01 |
| Terminated | Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukem Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a) | Phase 2 | 2008-03-01 |
| Completed | Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Trans Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | 2008-02-01 |
| Terminated | Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Dono Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 1 | 2007-10-05 |
| Completed | Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma Recurrent Melanoma, Stage IV Melanoma | Phase 1 / Phase 2 | 2007-09-01 |
| Active Not Recruiting | Improving Outcomes Assessment in Chronic GVHD Chronic Graft Versus Host Disease | — | 2007-09-01 |
| No Longer Available | Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Inf Infection, Precancerous/Nonmalignant Condition | — | 2007-09-01 |
| Terminated | Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2007-09-01 |
| Completed | Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Re B-cell Chronic Lymphocytic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma | Phase 1 | 2007-08-01 |
| Completed | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement Breast Cancer | — | 2007-05-01 |
| Completed | Yoga Study in Breast Cancer Patients Breast Cancer | N/A | 2007-05-01 |
| Completed | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | 2007-04-01 |
| Completed | Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymph Lymphoid Leukemia in Remission, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 2 | 2007-02-01 |
| Completed | Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Acute Myeloid Leukemia in Remission, de Novo Myelodysplastic Syndrome, Fanconi Anemia | Phase 2 | 2007-02-01 |
| Completed | Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant f DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma | Phase 2 | 2007-01-10 |
| Completed | Colombian Screening Mammography Project Breast Cancer | N/A | 2007-01-01 |
| Terminated | Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, T Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes | Phase 2 | 2006-12-01 |
| Completed | Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | N/A | 2006-12-01 |
| Completed | Effects of Garlic Supplements on Opioids in Healthy Volunteers Healthy, No Evidence of Disease | Phase 4 | 2006-11-01 |
| Completed | Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis Systemic Scleroderma, Severe Systemic Sclerosis | Phase 1 / Phase 2 | 2006-09-01 |
| Completed | Spouses/Partners Expressing Their Thoughts After Transplant Cancer, Hematopoietic Stem Cell Transplantation | N/A | 2006-08-01 |
| Unknown | Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previo Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2006-08-01 |
| Completed | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Ha Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | Phase 2 | 2006-07-01 |
| Completed | Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Tre Immunodeficiency Syndrome, Non-Cancer Diagnosis | Phase 2 | 2006-06-01 |
| Completed | Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | N/A | 2006-06-01 |
| Completed | Carbohydrates and Related Biomarkers Healthy, Overweight | N/A | 2006-06-01 |
| Terminated | Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant a Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder | Phase 2 | 2006-05-24 |
| Completed | Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease Aft Cancer | Phase 2 | 2006-05-01 |
| Completed | A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Bloo Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1 | 2006-04-01 |
| Completed | Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacroli Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia | Phase 2 | 2006-03-01 |
| Terminated | Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Aplastic Anemia | Phase 1 | 2006-02-01 |
| Completed | Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic G Aplastic Anemia | Phase 2 | 2006-02-01 |
| Completed | Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Adult Acute Myeloid Leukemia in Remission | Phase 3 | 2006-01-01 |
| Completed | Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treati Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome | Phase 2 | 2006-01-01 |
| Completed | Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patient Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2005-11-18 |
| Completed | Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Mammographic Breast Density | N/A | 2005-11-01 |
| Completed | Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2005-11-01 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2005-11-01 |
| Completed | Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Trea Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2005-09-01 |
| Completed | Move and Moderate in Balance Overweight, Obesity, Sedentary | N/A | 2005-09-01 |
| Completed | Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response Psychological Stress | Phase 1 | 2005-09-01 |
| Completed | Effects of Garlic Supplements on Drug Metabolism Healthy | — | 2005-07-01 |
| Completed | Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma | Phase 3 | 2005-07-01 |
| Completed | Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Leukemia, Lymphoma, Myelodysplastic Syndromes | Phase 2 | 2005-05-01 |
| Completed | Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Prima Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2005-05-01 |
| Completed | Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Secondary Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2005-04-01 |
| Completed | Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone S Cardiovascular Complications, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children | — | 2005-04-01 |
| Completed | Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Leukemia | Phase 1 / Phase 2 | 2005-04-01 |
| Completed | Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon HIV-1 and HSV-2 Coinfection, HIV Infections | Phase 2 / Phase 3 | 2005-03-01 |
| Completed | Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofe Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2005-03-01 |
| Completed | Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chron Leukemia | Phase 2 | 2005-02-01 |
| Completed | Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma | Phase 1 | 2005-01-01 |
| Completed | Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia Leukemia | Phase 1 | 2005-01-01 |
| Completed | Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cel Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma | Phase 2 | 2004-12-01 |
| Completed | Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweigh Breast Cancer, Obesity, Weight Changes | N/A | 2004-12-01 |
| Completed | Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic Lymphocytic Leukemia | Phase 2 | 2004-11-01 |
| Completed | Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peri Ovarian Cancer, Peritoneal Cavity Cancer | Phase 1 | 2004-10-01 |
| Completed | Promoting Activity and Changes in Eating (PACE) to Reduce Obesity Obesity, Cardiovascular Diseases, Heart Diseases | N/A | 2004-09-01 |
| Completed | Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Tran Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 2 | 2004-09-01 |
| Completed | Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced H Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia | Phase 2 | 2004-08-01 |
| Completed | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 1 / Phase 2 | 2004-06-01 |
| Completed | Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating B-cell Chronic Lymphocytic Leukemia, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma | Phase 2 | 2004-06-01 |
| Completed | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | Phase 1 / Phase 2 | 2004-06-01 |
| Completed | Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia Leukemia | Phase 2 | 2004-05-01 |
| Completed | Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal Zone Lymphoma | Phase 2 | 2004-05-01 |
| Completed | Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone To Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2004-04-01 |
| Completed | Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | Phase 2 | 2004-03-01 |
| Completed | Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positiv Leukemia | Phase 1 / Phase 2 | 2004-01-01 |
| Completed | Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treatin Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma | Phase 3 | 2003-10-01 |
| Completed | Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Mali Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 1 / Phase 2 | 2003-09-01 |
| Completed | Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Trea Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 2 | 2003-08-01 |
| Completed | Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Graft Versus Host Disease, Leukemia, Lymphoma | Phase 1 / Phase 2 | 2003-08-01 |
| Completed | Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease Kidney Cancer, Leukemia, Lymphoma | Phase 1 / Phase 2 | 2003-08-01 |
| Completed | Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autolo Multiple Myeloma, Plasma Cell Neoplasm | N/A | 2003-07-01 |
| Completed | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematol Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia | Phase 1 / Phase 2 | 2003-06-01 |
| Completed | Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated W Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | 2003-06-01 |
| Completed | Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma Melanoma (Skin) | Phase 1 | 2003-05-01 |
| Terminated | Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Trans Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 2 | 2003-05-01 |
| Completed | Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Ce Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia | Phase 2 | 2003-05-01 |
| Completed | Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor He Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2003-05-01 |
| Completed | Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Leukemia, Lymphoma, Myelodysplastic Syndromes | Phase 1 | 2003-04-01 |
| Completed | Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem C Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2003-04-01 |
| Completed | Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treatin B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia | Phase 2 | 2003-03-01 |
| Completed | Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients Lymphoma, Quality of Life | — | 2002-12-01 |
| Completed | Biological Therapy in Treating Patients With Metastatic Melanoma Melanoma (Skin) | Phase 1 | 2002-10-01 |
| Completed | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoi Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia | Phase 1 / Phase 2 | 2002-10-01 |
| Completed | Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients Wi Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2002-10-01 |
| Terminated | Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Le Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 1 / Phase 2 | 2002-09-01 |
| Completed | Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leuke Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | Phase 1 / Phase 2 | 2002-09-01 |
| Completed | Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primar Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2002-07-01 |
| Completed | Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment Graft Versus Host Disease | Phase 2 | 2002-04-01 |
| Completed | Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplant Cancer | Phase 3 | 2002-04-01 |
| Completed | Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary A Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 2 | 2002-04-01 |
| Completed | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | N/A | 2002-03-01 |
| Unknown | Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease Graft-vs-Host Disease | Phase 2 | 2002-03-01 |
| Completed | Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2002-01-01 |
| Completed | Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukem Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2002-01-01 |
| Completed | Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewi Metastatic Cancer, Sarcoma | Phase 1 / Phase 2 | 2001-11-01 |
| Completed | Biological Therapy in Treating Patients With Metastatic Melanoma Melanoma (Skin) | Phase 1 | 2001-11-01 |
| Completed | Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 2 | 2001-11-01 |
| Completed | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic My Leukemia, Myelodysplastic Syndromes | Phase 2 | 2001-10-01 |
| Completed | Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer Breast Cancer | — | 2001-10-01 |
| Completed | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients Wi Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific | Phase 2 | 2001-08-01 |
| Completed | Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Tr Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission | Phase 1 / Phase 2 | 2001-08-01 |
| Completed | Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Tr Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blastic Phase | Phase 2 | 2001-07-13 |
| Completed | Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplant Leukemia | Phase 1 / Phase 2 | 2001-07-01 |
| Completed | Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome Leukemia, Myelodysplastic Syndromes | Phase 2 | 2001-02-01 |
| Completed | Effect of Exercise on Biomarkers of Colon Cancer Risk Colon Cancer Prevention | Phase 2 / Phase 3 | 2001-01-01 |
| Completed | Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation Infection | Phase 3 | 2001-01-01 |
| Completed | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Imm Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | N/A | 2000-12-01 |
| Completed | Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marr Metabolism, Inborn Errors, Granulomatous Disease, Chronic | N/A | 2000-11-01 |
| Completed | Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autol Systemic Sclerosis, Systemic Lupus Erythematosus, Dermatomyositis | Phase 1 | 2000-11-01 |
| Completed | Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Leukemia, Myelodysplastic Syndromes | Phase 2 | 2000-10-01 |
| Completed | Hutchinson Study of High School Smoking Smoking Cessation | Phase 3 | 2000-09-01 |
| Completed | Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Leukemia, Lymphoma | Phase 1 | 2000-09-01 |
| Completed | Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Pa Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | 2000-08-01 |
| Completed | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Ly Breast Cancer, Gestational Trophoblastic Tumor, Kidney Cancer | Phase 2 | 2000-08-01 |
| Completed | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | Phase 1 / Phase 2 | 2000-07-01 |
| Completed | Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients Wit Systemic Sclerosis | Phase 2 | 2000-06-01 |
| Completed | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis Chronic Myeloproliferative Disorders | Phase 2 | 2000-05-01 |
| Completed | Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma Neuroblastoma | Phase 1 | 2000-05-01 |
| Completed | Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporin Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 / Phase 2 | 2000-05-01 |
| Completed | Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin Lymphoma | Phase 2 | 2000-03-01 |
| Completed | Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transpl Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer | Phase 1 / Phase 2 | 2000-02-01 |
| Completed | Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Pat Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | 2000-02-01 |
| Completed | Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Leukemia | Phase 2 | 2000-01-01 |
| Completed | Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusio Melanoma (Skin) | Phase 2 | 2000-01-01 |
| Completed | Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 1 | 2000-01-01 |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 1999-12-01 |
| Completed | Bone Marrow Transplantation in Treating Children With Sickle Cell Disease Sickle Cell Anemia | Phase 1 / Phase 2 | 1999-12-01 |
| Completed | Biological Therapy in Treating Patients With Myelodysplastic Syndrome Leukemia, Myelodysplastic Syndromes | Phase 2 | 1999-12-01 |
| Completed | Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating P Cervical Cancer, Vaginal Cancer | Phase 2 | 1999-11-01 |
| Completed | Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenola Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | N/A | 1999-11-01 |
| Completed | Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients Wi Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | N/A | 1999-11-01 |
| Completed | Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patie Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | 1999-10-01 |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Chronic Myeloproliferative Disorders, Leukemia, Lymphoma | Phase 2 | 1999-10-01 |
| Completed | Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Rela Lymphoma | Phase 2 | 1999-10-01 |
| Completed | Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or R Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma | Phase 1 / Phase 2 | 1999-09-01 |
| Terminated | Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymph Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 1 | 1999-09-01 |
| Completed | Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 1 | 1999-07-27 |
| Completed | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Leukemia | Phase 1 / Phase 2 | 1999-06-01 |
| Completed | Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treati Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | 1999-06-01 |
| Completed | Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Pa Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 1 / Phase 2 | 1999-03-01 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia Leukemia, Lymphoma | Phase 1 / Phase 2 | 1999-02-01 |
| Completed | Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Tra Leukemia | Phase 2 | 1999-02-01 |
| Completed | Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treati Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Phase 2 | 1999-02-01 |
| Completed | Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Cancer | Phase 3 | 1999-02-01 |
| Completed | Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Tra Leukemia | Phase 2 | 1999-02-01 |
| Completed | Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients Wit Breast Cancer | Phase 2 | 1999-01-01 |
| Completed | Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or R Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-01-01 |
| Completed | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Leukemia, Lymphoma, Myelodysplastic Syndromes | Phase 2 | 1998-12-01 |
| Completed | Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Leukemia, Myelodysplastic Syndromes | Phase 1 | 1998-12-01 |
| Completed | Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | 1998-10-13 |
| Completed | Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bo Cancer | Phase 3 | 1998-10-01 |
| Completed | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transp Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | Phase 2 | 1998-08-01 |
| Completed | Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transpla Cancer | N/A | 1998-08-01 |
| Completed | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage Breast Cancer | Phase 3 | 1998-07-01 |
| Completed | Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia Fanconi Anemia | Phase 1 | 1998-06-01 |
| Completed | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients Wit Sarcoma | Phase 1 | 1998-03-01 |
| Completed | Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cel Infection | Phase 3 | 1998-03-01 |
| Completed | Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngen Multiple Sclerosis | Phase 1 | 1997-12-01 |